Joshua A. Grass
Vice President, Business & Corporate Development
Mr. Grass joined BioMarin in 2002 with more than 10 years of experience in biotechnology product development, finance and strategy. Since joining BioMarin he has been directly involved in raising approximately $1 billion in capital for BioMarin. From 2002 to the present Mr. Grass has worked closely with or as part of the senior management team on the development strategy, licensing and alliance management for BioMarin’s three marketed products and several development stage products and in 2006 led the divestiture of the Orapred assets. Mr. Grass currently leads the Business and Corporate Development function responsible for technology licensing, acquisitions and corporate strategy.
For two years prior to joining BioMarin, Mr. Grass was an Associate at the investment bank Vrolyk & Company, focusing on mergers and acquisitions and private equity financings. Prior to that Mr. Grass was a Research Analyst at BioMedical Insights where he conducted strategic market research for established biopharmaceutical and emerging product development companies. Mr. Grass also worked in the biotechnology equity research group at SG Cowen between his first and second year of graduate studies in business.
Mr. Grass started his career in biotechnology as a Research Scientist at Cerus Corporation where for five years he focused on research and development in the areas of cell biology and immunology. Mr. Grass holds a B.S. in Biology from California Polytechnic State University in San Luis Obispo and an MBA in Finance from the University of Rochester in Rochester, New York.